Finally, tumour EVs can induce metabolic alterations in neighbouring tumour or microenvironment cells, as demonstrated for EVs carrying functional GLUT-1 deriving from mutant KRAS colorectal cancer cells, induce glucose uptake, lactate and glutamate production in colonic epithelial cells [192]. Here, SLC2A1 is linked to neoplasm.